FROI – Fero Industries, Inc. – Hot Stock

Fero Industries, Inc FROI

FROI had a great day following our pre-market alert yesterday, seeing a high of .015, and closing 30% in the green at .011. From the day’s low of .0075, that’s an intraday gain of 100% on around seven times the 10-day average volume. Not too shabby for our first day of coverage on a new stock.

There appeared to be resistance in the .0135 to .015 area, then the stock dipped to find support at a penny. Its always important to monitor support and resistance levels, watching as closely as possible.

This was a short term winner for us, but with the developments going on internally within the company, this could be a play that we stick with all the way through the beginning months of 2012. We’ll want to see how the company’s planned expansion of Sucanon to the Middle East goes before we even think about losing interest in this one. .

More Info can be found at www.feroindustries.com

We would like to extend our deepest heartfelt holiday greetings to all, howsoever you and yours celebrate the season. We’ll see you all again when trading resumes, stay safe and happy!

Fero Industries, Inc. | FROI | Hot Stock

Fero Industries, Inc FROI

After much anticipation, our new pick is finally here. FROI poses a unique opportunity for us to involve ourselves with a stock that is poised for rapid growth. FROI’s Sucanon nutraceutical is one of only three products in the world with approval under the category of ‘Insulin Sensitizer’, used to treat Type 2 Diabetes.

Sucanon® has been approved for prescription sale in China , Peru and Mexico (Where it is distributed over-the-counter there under an exclusive agreement with Merck S.A. de C.V.), and as of this morning’s PR, will now also be expanding its consumer base into the Middle East.

We are particularly excited about this play, not only because they have a niche in a multi-billion dollar market, but because of the ripening conditions on the chart as well.

CALGARY, Alberta , Dec. 22, 2011 /PRNewswire/ — Fero Industries, Inc. (OTCQB: FROI.PK – News), the exclusive owner, producer and distributor of the Type-II diabetes treatment Sucanon®, is pleased to announce that it has entered into a Distribution Agreement with Premium Pharma Co. for the marketing and distribution of Sucanon® in several countries in the region ( Egypt , Saudi Arabia , United Arab Emirates , Bahrain , Kuwait , Qatar , Oman , Jordan , Lebanon , Iraq , Sudan and Libya ).

The 5-year Distribution Agreement calls for a minimum purchase of $13 million USD and gives Premium Pharma the exclusive right to market and sell Sucanon® through its established distribution channels and will begin shortly the regulatory process with the Ministries of Health for the sale of Sucanon®. Fero is also taking the necessary steps to comply with the United States government for this Agreement, and the companies expect to complete the licencing process and commence shipping of Sucanon® within a year.
Also have a look at this FROI video chart, and take note of the fact that BARCHART is giving FROI a “Buy” Rating

More Info can be found at www.feroindustries.com

BioSante Pharmaceuticals, Inc. | BPAX

BioSante Pharmaceuticals, Inc. BPAX

BPAX continues to look better with its second consecutive day of gains. The stock hit a high of .51, and has held a good portion of that gain heading into the close, on more than 3x the 3mo. average volume.

We’ve stated, even just this morning, that BPAX is going to provide folks with some good opportunities moving forward as it continues to recover from a monumental pullback these past few weeks. We’ve been proven right for the second day running.

Again, a reminder to be on a sharp lookout for our newsletter tomorrow, as it will include a brand new pick that has us really excited.

It is a sub-penny play with one of only three herbal nutraceutical products approved anywhere for insulin sensitization. This company is operating in a multi-billion dollar sector, and appears to be poised for astronomical growth. It recently has bounced off of its 52-week low, and is making higher lows since then. Tune in tomorrow for the symbol.